Rivulet Media Inc (fka RIVU)

[LaddyMan]

**FOR NEW BMSN EYES**

Why it is about to go nuts here...courtesy of cinvestor.

Let's analyze what the company is focused on: HemaXellerate I - testing by an outside reputable company CRL whose report is due soon.... (Charles River Labs. audited report either with the FDA or on its way soon. Expected approval for Phase 1 clinical trials for this exciting drug to be announced within 30 days of FDA receipt of the report)

dCellVax - continuing development with hiring of Dr. Kesari, a cancer expert working in one of the few NCRI certified clinics who is partnering with RGBP to not only revise the IND for dCellVax for greatly chance of successs, but is interested in applying the research to glioma.

NR2F6 -this could be the golden egg, research showing the possibility of maturing cancel stem cells into healthy cells through differentiation.

BORIS - T cell immuno therapy studies that are gaining ground elsewhere, while RGBP holds IP patents.

RGBP